Author

Harriet Kemp

Institute of Cancer ResearchORCID 0009-0005-5746-2200Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 3 Organism:human· 3 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Syed HaideriD· 3 shared Christopher J. LordiD· 2 shared Katarzyna TomczykiD· 2 shared Kate MackieiD· 2 shared Nichola JohnsoniD· 2 shared Olivia FletcheriD· 2 shared Selin Sevgi· 2 shared Alicia F. C. OkinesiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Syed HaiderORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintApr 10, 2026

Functional annotation of breast cancer risk loci implicates perturbation of FILIP1L expression in mammary fibroblasts in influencing breast cancer risk.

Alisa Zvereva, Harriet Kemp, Andrea Gillespie…·Nichola Johnson

The paper identifies a breast cancer risk locus by analyzing functional variants and target genes in mammary fibroblasts, showing their non-autonomous impact on breast cancer risk.

DOI 10.64898/2026.04.09.26350488

humanChIP-seq

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintMar 3, 2026

Massively parallel functional profiling identifies CCDC88C as a risk gene for ER-positive breast cancer

Kate Mackie, Harriet Kemp, Andrea Gunnell…·Syed Haider

The paper identifies CCDC88C as a risk gene for ER-positive breast cancer by analyzing functional variants from GWAS signals using a massively parallel reporter assay.

DOI 10.64898/2026.03.02.26347419

humanGWAS summary statistics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 27, 2025

LOX inhibition disrupts a collagen-integrin-MYC axis as a translatable targeting strategy in invasive lobular carcinoma

Renée L. Flaherty, Flavia Hughes, George Sflomos…·Cathrin Brisken

LOX inhibition disrupts a collagen-integrin-MYC axis in ILC, halting tumor growth and metastasis with minimal toxicity, offering a new therapeutic strategy.

DOI 10.1101/2025.08.27.672618

humanbulk RNA-seq

𝕏 PostBluesky